myEANM account
Log into your myEANM account or create a new one.
While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies, the radionuclide is non-ideal imaging qualities mostly due to its low dosage, and also brings with it radiation safety challenges. This webinar will present both sides of Zr-89 imaging, the clinically relevant opportunities for the radionuclide, and the quantification challenges, handling and the safety aspects of Zr-89.
Learning Objectives: The aim of this webinar is to show the potential and the challenges of Zr-89 imaging.
Log into your myEANM account or create a new one.
Access the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations
Enter the course store, make your selection and check out.
Find your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE
The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org